Cargando…
Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM
Rapid screening and identification of potential candidate compounds are very important to understand the mechanism of drugs for the treatment of Alzheimer's disease (AD) and greatly promote the development of new drugs. In order to greatly improve the success rate of screening and reduce the co...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357977/ https://www.ncbi.nlm.nih.gov/pubmed/35959292 http://dx.doi.org/10.3389/fnagi.2022.931729 |
_version_ | 1784763829773664256 |
---|---|
author | Yang, Bin Bao, Wenzheng Hong, Shichai |
author_facet | Yang, Bin Bao, Wenzheng Hong, Shichai |
author_sort | Yang, Bin |
collection | PubMed |
description | Rapid screening and identification of potential candidate compounds are very important to understand the mechanism of drugs for the treatment of Alzheimer's disease (AD) and greatly promote the development of new drugs. In order to greatly improve the success rate of screening and reduce the cost and workload of research and development, this study proposes a novel Alzheimer-related compound identification algorithm namely forgeNet_SVM. First, Alzheimer related and unrelated compounds are collected using the data mining method from the literature databases. Three molecular descriptors (ECFP6, MACCS, and RDKit) are utilized to obtain the feature sets of compounds, which are fused into the all_feature set. The all_feature set is input to forgeNet_SVM, in which forgeNet is utilized to provide the importance of each feature and select the important features for feature extraction. The selected features are input to support vector machines (SVM) algorithm to identify the new compounds in Traditional Chinese Medicine (TCM) prescription. The experiment results show that the selected feature set performs better than the all_feature set and three single feature sets (ECFP6, MACCS, and RDKit). The performances of TPR, FPR, Precision, Specificity, F1, and AUC reveal that forgeNet_SVM could identify more accurately Alzheimer-related compounds than other classical classifiers. |
format | Online Article Text |
id | pubmed-9357977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93579772022-08-10 Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM Yang, Bin Bao, Wenzheng Hong, Shichai Front Aging Neurosci Aging Neuroscience Rapid screening and identification of potential candidate compounds are very important to understand the mechanism of drugs for the treatment of Alzheimer's disease (AD) and greatly promote the development of new drugs. In order to greatly improve the success rate of screening and reduce the cost and workload of research and development, this study proposes a novel Alzheimer-related compound identification algorithm namely forgeNet_SVM. First, Alzheimer related and unrelated compounds are collected using the data mining method from the literature databases. Three molecular descriptors (ECFP6, MACCS, and RDKit) are utilized to obtain the feature sets of compounds, which are fused into the all_feature set. The all_feature set is input to forgeNet_SVM, in which forgeNet is utilized to provide the importance of each feature and select the important features for feature extraction. The selected features are input to support vector machines (SVM) algorithm to identify the new compounds in Traditional Chinese Medicine (TCM) prescription. The experiment results show that the selected feature set performs better than the all_feature set and three single feature sets (ECFP6, MACCS, and RDKit). The performances of TPR, FPR, Precision, Specificity, F1, and AUC reveal that forgeNet_SVM could identify more accurately Alzheimer-related compounds than other classical classifiers. Frontiers Media S.A. 2022-07-25 /pmc/articles/PMC9357977/ /pubmed/35959292 http://dx.doi.org/10.3389/fnagi.2022.931729 Text en Copyright © 2022 Yang, Bao and Hong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Aging Neuroscience Yang, Bin Bao, Wenzheng Hong, Shichai Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title | Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title_full | Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title_fullStr | Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title_full_unstemmed | Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title_short | Alzheimer-Compound Identification Based on Data Fusion and forgeNet_SVM |
title_sort | alzheimer-compound identification based on data fusion and forgenet_svm |
topic | Aging Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357977/ https://www.ncbi.nlm.nih.gov/pubmed/35959292 http://dx.doi.org/10.3389/fnagi.2022.931729 |
work_keys_str_mv | AT yangbin alzheimercompoundidentificationbasedondatafusionandforgenetsvm AT baowenzheng alzheimercompoundidentificationbasedondatafusionandforgenetsvm AT hongshichai alzheimercompoundidentificationbasedondatafusionandforgenetsvm |